Alzheimer's Drug Co. Alzheon Again Nixes IPO Plans
Alzheimer's-focused biotechnology firm Alzheon Inc. said Wednesday it is no longer looking to go public, marking the second time the Framingham, Massachusetts-based company has canceled plans for an initial public offering...To view the full article, register now.
Already a subscriber? Click here to view full article